Penumbra (NYSE:PEN) announced additional results from its STORM-PE trial of computer-assisted vacuum thrombectomy (CAVT).
Key points A 53-year-old woman with rectosigmoid adenocarcinoma was seen in the radiation oncology clinic for her fifth and final fraction of neoadjuvant radiotherapy, where she reported chills, ...
9don MSN
General anesthesia during clot-removal surgery leads to better neurological outcomes at 3 months
Patients who undergo general anesthesia while receiving a specialized surgery to treat strokes have better outcomes than ...
Khaleej Times on MSN
XCath endovascular robotic system successfully performs its first-in-human brain aneurysm procedures
Brain aneurysms a critical health concern affecting 1 in 50 people and demand technical advances for improved outcomes ...
Sharjah, United Arab Emirates – XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, ...
A DAD-to-be may never hold his baby after paramedics allegedly brushed off his stroke as drunk behaviour. Ion Chiperi, 22, is ...
Charlemagne Hobour must use a wheelchair for the rest of his life after St. Joseph and Good Samaritan University hospitals ...
EXCLUSIVE: Ion Chiperi, 22, was in bed with his partner, Doina, who is eight months pregnant, when he suddenly began to feel ...
XCath today announced the successful first-in-human use of its EVR robotic system to treat three patients with complex brain ...
Scottish and US team calls procedure potential ‘game changer’ that could transform stroke treatment if approved for patient use - Anadolu Ajansı ...
PE RCT data presented at the VIVA 2025 Conference showed PE patients treated with CAVT in combination with anticoagulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback